glp-1 receptor agonist diarrhea management GLP-1RA Essentials in Gastroenterology: Side Effect Management, Precautions for Endoscopy and Applications for Gastrointestinal Disease Treatment Mechanisms of action of GLP-1
Description
For diabetes patients, A1c reductions of approximately 1.0-1.5 percentage points are common with GLP-1 receptor agonists, while tirzepatide has shown reductions of up to 2.0-2.3 percentage points in clinical trials
In the last couple years, nonalcoholic fatty liver disease (NAFLD) has become the No
A big part of the problem starts with Medicare
H.et al (2019)
doi: 10.1164/rccm.202004-0993OC
